All News about Biotricity Inc
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_14215.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_8423.jpeg?width=1200&height=800&fit=crop)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_20570.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_2144.jpeg?width=1200&height=800&fit=crop)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/5328.png?v=0)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_12355.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_11511.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/5328.png?v=0)
![](https://cdn.benzinga.com/files/images/story/2022/06/29/image9.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/06/16/mid-day_movers_image_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/06/01/yesterdays_movers.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_8789.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_9441.jpeg?width=1200&height=800&fit=crop)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/5328.png?v=0)
![](https://cdn.benzinga.com/files/images/story/2022/05/20/yesterdays_movers.png?width=1200&height=800&fit=crop)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/5328.png?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/5328.png?v=0)
Biotricity to Launch Commercial Sales of Its Disruptive Cardiac Monitoring Device, Biotres in April 2022
March 22, 2022
From Biotricity, Inc.
Via AccessWire
Exposures
Product Safety
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/5328.png?v=0)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/analyst_ratings_image_4191.jpeg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/5328.png?v=0)
From Biotricity, Inc.
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/5328.png?v=0)
Biotricity Now Taking Pre-Orders for its Biotres Wireless Wearable Cardiac Monitoring Device
February 23, 2022
From Biotricity, Inc.
Via AccessWire
Exposures
Product Safety
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/5328.png?v=0)
Biotricity Releases Fiscal 2022 Third Quarter Financial Results
February 14, 2022
From Biotricity, Inc.
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.